Aakash

Akash Puranik

Promoter MD & CEO
  • Akash is the driving force behind building the API business of the company globally
  • Formerly, Vice President – Emerging Markets at Biocon Limited. He was responsible for total sales of about USD 225 mn across 70 countries.
  • Played a pivotal role in establishing Biocon’s presence in more than 70 countries for their Generic APIs/ Commercialization of Biosimilars
  • B.Pharm, Masters in Bioprocess Technology - UDCT

“I am excited to be at the forefront of Symbio’s successful journey. I attribute this success to the relationships that have been carefully nurtured over the last few decades. These relationships along with the hard work of a passionate team at Symbio has helped us, a group of first-generation entrepreneurs – with no business background, to grow from a trading company to a full-fledged manufacturing organization in just over a decade. We now have two manufacturing facilities of global quality standards and a state-of-the-art R&D facility that are fully focused on manufacturing and development of APIs. Our well-defined corporate structure enables us to deliver value to our stakeholders that include clients, suppliers, investors, and employees.

People are at the core of this organisation. I believe that this is an organisation where people look for exciting opportunities. I trust in nurturing long term relationships, both inside & outside the organisation, to create value for our partners along with us.

I believe that the journey of Symbio has just begun, and we have a long way to go. Having received a CEP for Minoxidil, Symbio has already begun its presence in European markets. With continued efforts, we plan to get our facilities approved by US FDA and other regulatory bodies which will help us create a global footprint for our APIs. Symbio is also happy to invite customers to get their products (APIs & Intermediates) manufactured at our facilities through CDMO model.

This is a journey that has started from scratch and with continued support from our internal and external stakeholders, we hope to continue our growth story.”

– Akash
Promoter MD & CEO